The University of Chicago Header Logo

Connection

John Fung to Male

This is a "connection" page, showing publications John Fung has written about Male.
Connection Strength

1.723
  1. Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. Transplantation. 2017 Feb; 101(2):341-349.
    View in: PubMed
    Score: 0.029
  2. Liver transplantation for nonalcoholic steatohepatitis in young patients. Transpl Int. 2016 Apr; 29(4):418-24.
    View in: PubMed
    Score: 0.027
  3. Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2012 May; 10(5):540-6.
    View in: PubMed
    Score: 0.020
  4. Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant. 2010 Dec; 10(12):2665-72.
    View in: PubMed
    Score: 0.019
  5. Robotic versus laparoscopic resection of liver tumours. HPB (Oxford). 2010 Oct; 12(8):583-6.
    View in: PubMed
    Score: 0.019
  6. Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation. Clin Transplant. 2010 Sep-Oct; 24(5):701-8.
    View in: PubMed
    Score: 0.018
  7. Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients? Surgery. 2010 Sep; 148(3):582-8.
    View in: PubMed
    Score: 0.018
  8. Side-to-side cavocavostomy with an endovascular stapler: Rescue technique for severe hepatic vein and/or inferior vena cava outflow obstruction after liver transplantation using the piggyback technique. Liver Transpl. 2009 Jan; 15(1):49-53.
    View in: PubMed
    Score: 0.016
  9. Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation. Liver Transpl. 2008 Jan; 14(1):46-52.
    View in: PubMed
    Score: 0.015
  10. Dental health status of liver transplant candidates. Liver Transpl. 2007 Feb; 13(2):280-6.
    View in: PubMed
    Score: 0.014
  11. Preservation solutions in liver transplantation: what are the options? Liver Transpl. 2006 Feb; 12(2):196-8.
    View in: PubMed
    Score: 0.013
  12. Is adult-to-adult living donor liver transplantation a viable option for liver replacement? Nat Clin Pract Gastroenterol Hepatol. 2006 Feb; 3(2):70-1.
    View in: PubMed
    Score: 0.013
  13. Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation. 2005 Dec 27; 80(12):1692-8.
    View in: PubMed
    Score: 0.013
  14. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl. 2005 Nov; 11(11):1425-30.
    View in: PubMed
    Score: 0.013
  15. Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation. Transplantation. 2005 Sep 27; 80(6):859-64.
    View in: PubMed
    Score: 0.013
  16. Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl. 2005 Jun; 11(6):679-83.
    View in: PubMed
    Score: 0.013
  17. Revascularization of the gastroduodenal artery in a pancreas allograft from a donor with a replaced right hepatic artery. Transplantation. 2005 Feb 27; 79(4):503.
    View in: PubMed
    Score: 0.013
  18. Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant. 2004 Dec; 18(6):661-5.
    View in: PubMed
    Score: 0.012
  19. The pitfall of the cystic duct biliary anastomosis in right lobe living donor liver transplantation. Liver Transpl. 2004 Dec; 10(12):1549-50.
    View in: PubMed
    Score: 0.012
  20. [Analysis of causes of late mortality in liver transplant recipients]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004 Sep; 16(9):547-51.
    View in: PubMed
    Score: 0.012
  21. Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience. Transplantation. 2004 Mar 27; 77(6):897-902.
    View in: PubMed
    Score: 0.012
  22. Outcomes in 139 cases of biliary tract reconstructions from a transplant surgery center. Exp Clin Transplant. 2003 Dec; 1(2):73-8.
    View in: PubMed
    Score: 0.012
  23. Liver transplantation for growing teratoma syndrome: report of a case. Liver Transpl. 2003 Nov; 9(11):1222-4.
    View in: PubMed
    Score: 0.011
  24. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl. 2003 Sep; 9(9):954-60.
    View in: PubMed
    Score: 0.011
  25. Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation. Exp Clin Transplant. 2003 Jun; 1(1):48-55.
    View in: PubMed
    Score: 0.011
  26. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl. 2003 Mar; 9(3):239-47.
    View in: PubMed
    Score: 0.011
  27. Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography. AJR Am J Roentgenol. 2002 Nov; 179(5):1281-6.
    View in: PubMed
    Score: 0.011
  28. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection. Liver Transpl. 2002 Nov; 8(11):1007-13.
    View in: PubMed
    Score: 0.011
  29. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002 Oct; 236(4):429-36; discussion 436-7.
    View in: PubMed
    Score: 0.011
  30. Experiences relating to management of biliary tract complications following liver transplantation in 96 cases. Chin Med J (Engl). 2002 Oct; 115(10):1533-7.
    View in: PubMed
    Score: 0.011
  31. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl. 2002 Sep; 8(9):841-5.
    View in: PubMed
    Score: 0.011
  32. Transjugular intrahepatic portosystemic shunt for liver transplantation. Hepatobiliary Pancreat Dis Int. 2002 May; 1(2):179-82.
    View in: PubMed
    Score: 0.010
  33. Five cases of fulminant hepatitis due to herpes simplex virus in adults. Dig Dis Sci. 2002 Apr; 47(4):750-4.
    View in: PubMed
    Score: 0.010
  34. Bioartificial liver assist devices in support of patients with liver failure. Hepatobiliary Pancreat Dis Int. 2002 Feb; 1(1):18-25.
    View in: PubMed
    Score: 0.010
  35. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transpl. 2002 Jan; 8(1):40-6.
    View in: PubMed
    Score: 0.010
  36. Fungal infection in liver transplantation. Transpl Infect Dis. 2002; 4 Suppl 3:18-23.
    View in: PubMed
    Score: 0.010
  37. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report. Transplantation. 2001 Sep 27; 72(6):1091-7.
    View in: PubMed
    Score: 0.010
  38. Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. Transplantation. 2001 Apr 27; 71(8):1102-6.
    View in: PubMed
    Score: 0.010
  39. Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus. J Clin Pharmacol. 2001 Mar; 41(3):268-76.
    View in: PubMed
    Score: 0.010
  40. Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. Transplantation. 2001 Jan 27; 71(2):267-71.
    View in: PubMed
    Score: 0.009
  41. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg. 2000 Oct; 232(4):490-500.
    View in: PubMed
    Score: 0.009
  42. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation. Liver Transpl. 2000 Jul; 6(4):434-9.
    View in: PubMed
    Score: 0.009
  43. Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression. Transplant Proc. 2000 May; 32(3):663-4.
    View in: PubMed
    Score: 0.009
  44. Split-liver transplantation: a comparison of ex vivo and in situ techniques. J Pediatr Surg. 2000 Feb; 35(2):283-9; discussion 289-90.
    View in: PubMed
    Score: 0.009
  45. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg. 1999 Sep; 5(5):421-8.
    View in: PubMed
    Score: 0.009
  46. Preservation injury and acute rejection of rat intestinal grafts: protection afforded by pyruvate. J Gastrointest Surg. 1999 Sep-Oct; 3(5):549-54.
    View in: PubMed
    Score: 0.009
  47. Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure. J Heart Lung Transplant. 2019 09; 38(9):997-999.
    View in: PubMed
    Score: 0.008
  48. Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients. J Transpl Coord. 1999 Jun; 9(2):101-3.
    View in: PubMed
    Score: 0.008
  49. Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation. 1999 Apr 27; 67(8):1191-3.
    View in: PubMed
    Score: 0.008
  50. Minimally invasive resection of posterosuperior liver tumors in the supine position using intra-abdominal trocars. Surg Endosc. 2020 02; 34(2):536-543.
    View in: PubMed
    Score: 0.008
  51. Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events. Liver Transpl Surg. 1999 Mar; 5(2):144-50.
    View in: PubMed
    Score: 0.008
  52. Early Infectious Complications After Total Pancreatectomy with Islet Autotransplantation: a Single Center Experience. J Gastrointest Surg. 2019 11; 23(11):2201-2210.
    View in: PubMed
    Score: 0.008
  53. Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome. Blood. 1999 Feb 01; 93(3):1113-4.
    View in: PubMed
    Score: 0.008
  54. A Comparison of the Initial Cost Associated With Resection Versus Laparoscopic Radiofrequency Ablation of Small Solitary Colorectal Liver Metastasis. Surg Laparosc Endosc Percutan Tech. 2018 Dec; 28(6):371-374.
    View in: PubMed
    Score: 0.008
  55. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. Transplantation. 1998 Nov 27; 66(10):1395-8.
    View in: PubMed
    Score: 0.008
  56. Assessment of simple indices based on a single fasting blood sample as a tool to estimate beta-cell function after total pancreatectomy with islet autotransplantation - a prospective study. Transpl Int. 2019 03; 32(3):280-290.
    View in: PubMed
    Score: 0.008
  57. Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transpl Surg. 1998 Nov; 4(6):448-54.
    View in: PubMed
    Score: 0.008
  58. Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence from an International Randomized Trial of Everolimus-Based Immunosuppression. Ann Transplant. 2018 Oct 26; 23:751-757.
    View in: PubMed
    Score: 0.008
  59. Role of splenectomy in human liver transplantation under modern-day immunosuppression. Dig Dis Sci. 1998 Sep; 43(9):1931-7.
    View in: PubMed
    Score: 0.008
  60. Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications. Exp Clin Transplant. 2018 08; 16(4):439-445.
    View in: PubMed
    Score: 0.008
  61. Reconstruction of an abnormal hepatic vein in a donor liver: a case report. Transplantation. 1998 May 15; 65(9):1265-6.
    View in: PubMed
    Score: 0.008
  62. A new technique for hepatic parenchymal transection using an articulating bipolar 5 cm radiofrequency device: results from the first 100 procedures. HPB (Oxford). 2018 09; 20(9):829-833.
    View in: PubMed
    Score: 0.008
  63. Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion. Liver Transpl. 2018 02; 24(2):233-245.
    View in: PubMed
    Score: 0.008
  64. Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after islet transplantation. Am J Transplant. 2018 04; 18(4):990-997.
    View in: PubMed
    Score: 0.008
  65. Pain Control, Glucose Control, and Quality of Life in Patients With Chronic Pancreatitis After Total Pancreatectomy With Islet Autotransplantation: A Preliminary Report. Transplant Proc. 2017 Dec; 49(10):2333-2339.
    View in: PubMed
    Score: 0.008
  66. External Validation of the Newly Developed BETA-2 Scoring System for Pancreatic Islet Graft Function Assessment. Transplant Proc. 2017 Dec; 49(10):2340-2346.
    View in: PubMed
    Score: 0.008
  67. C-C Chemokine Receptor Type 2-Dependent Migration of Myeloid-Derived Suppressor Cells in Protection of Islet Transplants. Transplantation. 2017 08; 101(8):1793-1800.
    View in: PubMed
    Score: 0.007
  68. Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review. Surgery. 2017 09; 162(3):525-536.
    View in: PubMed
    Score: 0.007
  69. Quantitative assessment of the development of hepatoma in a buffalo rat model. Transplant Proc. 1997 Jun; 29(4):2263-4.
    View in: PubMed
    Score: 0.007
  70. Hemophilia Liver Transplantation Observational Study. Liver Transpl. 2017 06; 23(6):762-768.
    View in: PubMed
    Score: 0.007
  71. Liver transplantation in patients with incidental hepatocellular carcinoma/cholangiocarcinoma and intrahepatic cholangiocarcinoma: a single-center experience. Hepatobiliary Pancreat Dis Int. 2017 Jun; 16(3):264-270.
    View in: PubMed
    Score: 0.007
  72. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis. Lancet Gastroenterol Hepatol. 2017 08; 2(8):595-603.
    View in: PubMed
    Score: 0.007
  73. Evolution of a laparoscopic liver resection program: an analysis of 203 cases. Surg Endosc. 2017 10; 31(10):4150-4155.
    View in: PubMed
    Score: 0.007
  74. Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. Liver Transpl Surg. 1997 Mar; 3(2):118-29.
    View in: PubMed
    Score: 0.007
  75. Venous-right atrial bypass for superior vena cava thrombosis during orthotopic liver transplantation. Transplantation. 1997 Feb 15; 63(3):471-2.
    View in: PubMed
    Score: 0.007
  76. Hepatic transplantation during pregnancy and the puerperium. J Matern Fetal Med. 1997 Jan-Feb; 6(1):40-4.
    View in: PubMed
    Score: 0.007
  77. Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C. PLoS One. 2016; 11(11):e0166998.
    View in: PubMed
    Score: 0.007
  78. Role of donor hemodynamic trajectory in determining graft survival in liver transplantation from donation after circulatory death donors. Liver Transpl. 2016 11; 22(11):1469-1481.
    View in: PubMed
    Score: 0.007
  79. The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg. 1996 Aug; 183(2):117-25.
    View in: PubMed
    Score: 0.007
  80. Perioperative and oncologic outcomes of minimally invasive liver resection for colorectal metastases: A case-control study of 130 patients. Surgery. 2016 10; 160(4):1097-1103.
    View in: PubMed
    Score: 0.007
  81. Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation. Inflamm Bowel Dis. 2016 07; 22(7):1670-8.
    View in: PubMed
    Score: 0.007
  82. Role of Doppler Sonography in Early Detection of Splenic Steal Syndrome. J Ultrasound Med. 2016 Jul; 35(7):1393-400.
    View in: PubMed
    Score: 0.007
  83. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Immunology. 1996 May; 88(1):124-9.
    View in: PubMed
    Score: 0.007
  84. Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. Liver Transpl Surg. 1996 Mar; 2(2):139-47.
    View in: PubMed
    Score: 0.007
  85. Presence of retinal pericyte-reactive autoantibodies in diabetic retinopathy patients. Sci Rep. 2016 Feb 03; 6:20341.
    View in: PubMed
    Score: 0.007
  86. Cadaveric liver donors; what are the limits? Transplant Proc. 1996 Feb; 28(1):21-3.
    View in: PubMed
    Score: 0.007
  87. Safety and Efficacy of a New Bipolar Energy Device for Parenchymal Dissection in Laparoscopic Liver Resection. Surg Laparosc Endosc Percutan Tech. 2016 Feb; 26(1):21-4.
    View in: PubMed
    Score: 0.007
  88. Adenosine Increases Hepatic Artery Flow in Liver Transplant Recipients: A Pilot Study. Transplant Proc. 2016 Jan-Feb; 48(1):116-9.
    View in: PubMed
    Score: 0.007
  89. Oncologic results of laparoscopic liver resection for malignant liver tumors. J Surg Oncol. 2016 Feb; 113(2):127-9.
    View in: PubMed
    Score: 0.007
  90. Impact of donor age in liver transplantation from donation after circulatory death donors: A decade of experience at Cleveland Clinic. Liver Transpl. 2015 Dec; 21(12):1494-503.
    View in: PubMed
    Score: 0.007
  91. Enhancing kidney function with thrombolytic therapy following donation after cardiac death: a multicenter quasi-blinded prospective randomized trial. Clin Transplant. 2015 Dec; 29(12):1173-80.
    View in: PubMed
    Score: 0.007
  92. Autologous Reconstruction and Visceral Transplantation for Management of Patients With Gut Failure After Bariatric Surgery: 20 Years of Experience. Ann Surg. 2015 Oct; 262(4):586-601.
    View in: PubMed
    Score: 0.007
  93. Rejection triggers liver transplant tolerance: Involvement of mesenchyme-mediated immune control mechanisms in mice. Hepatology. 2015 Sep; 62(3):915-31.
    View in: PubMed
    Score: 0.006
  94. Hepatic artery angioplasty after liver transplantation: experience in 21 allografts. J Vasc Interv Radiol. 1995 Jul-Aug; 6(4):523-9.
    View in: PubMed
    Score: 0.006
  95. Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. Transplantation. 2015 Jul; 99(7):1455-62.
    View in: PubMed
    Score: 0.006
  96. Building clinical classifiers using incomplete observations--a neural network ensemble for hepatoma detection in patients with cirrhosis. Methods Inf Med. 1995 Jun; 34(3):253-8.
    View in: PubMed
    Score: 0.006
  97. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization. Immunology. 1995 May; 85(1):82-7.
    View in: PubMed
    Score: 0.006
  98. The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion. Transplant Proc. 1995 Feb; 27(1):511-2.
    View in: PubMed
    Score: 0.006
  99. Bone marrow augmentation in solid organ transplantation--any conclusions? Hepatology. 1995 Jan; 21(1):260-1.
    View in: PubMed
    Score: 0.006
  100. Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation. Liver Transpl. 2015 Jan; 21(1):101-11.
    View in: PubMed
    Score: 0.006
  101. Split liver transplantation using Hemiliver graft in the MELD era: a single center experience in the United States. Am J Transplant. 2014 Sep; 14(9):2072-80.
    View in: PubMed
    Score: 0.006
  102. Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation. J Gastroenterol Hepatol. 2014 Jun; 29(6):1250-7.
    View in: PubMed
    Score: 0.006
  103. FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. Transplant Proc. 1994 Jun; 26(3):1211.
    View in: PubMed
    Score: 0.006
  104. Cotransplantation with myeloid-derived suppressor cells protects cell transplants: a crucial role of inducible nitric oxide synthase. Transplantation. 2014 Apr 15; 97(7):740-7.
    View in: PubMed
    Score: 0.006
  105. FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation. 1994 Mar 27; 57(6):860-5.
    View in: PubMed
    Score: 0.006
  106. The successful use of telaprevir to treat hepatitis C recurrence after liver transplantation in an HIV co-infected patient. Transplantation. 2014 Jan 27; 97(2):e14-5.
    View in: PubMed
    Score: 0.006
  107. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66.
    View in: PubMed
    Score: 0.006
  108. Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial. Autoimmunity. 1994; 19(2):89-98.
    View in: PubMed
    Score: 0.006
  109. Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol. 1994; 2(1):61-7.
    View in: PubMed
    Score: 0.006
  110. Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastasis. Surgery. 2013 Sep; 154(3):556-62.
    View in: PubMed
    Score: 0.006
  111. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology. 1993 Jun; 17(6):1127-52.
    View in: PubMed
    Score: 0.006
  112. Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences. Transplant Proc. 1993 Feb; 25(1 Pt 1):362-3.
    View in: PubMed
    Score: 0.005
  113. Cytokine messenger RNA profiles in hamster-to-rat liver xenografts. Transplant Proc. 1993 Feb; 25(1 Pt 1):444-5.
    View in: PubMed
    Score: 0.005
  114. Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies. Hepatobiliary Pancreat Dis Int. 2013 Feb; 12(1):34-41.
    View in: PubMed
    Score: 0.005
  115. Multicentre results of stereotactic body radiotherapy for secondary liver tumours. HPB (Oxford). 2013 Nov; 15(11):851-7.
    View in: PubMed
    Score: 0.005
  116. The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood. 2013 Mar 07; 121(10):1760-8.
    View in: PubMed
    Score: 0.005
  117. Combined heart and liver transplantation: the Cleveland Clinic experience. Ann Thorac Surg. 2013 Jan; 95(1):179-82.
    View in: PubMed
    Score: 0.005
  118. Laparoscopic versus open resection of colorectal liver metastasis. Surg Endosc. 2013 Apr; 27(4):1138-43.
    View in: PubMed
    Score: 0.005
  119. Intestinal transplantation in composite visceral grafts or alone. Ann Surg. 1992 Sep; 216(3):223-33; discussion 233-4.
    View in: PubMed
    Score: 0.005
  120. A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology. 1992 Sep; 16(3):671-81.
    View in: PubMed
    Score: 0.005
  121. Predicting the discharge status after liver transplantation at a single center: a new approach for a new era. Liver Transpl. 2012 Jul; 18(7):796-802.
    View in: PubMed
    Score: 0.005
  122. Infectious complications after human small bowel transplantation. Transplant Proc. 1992 Jun; 24(3):1249-50.
    View in: PubMed
    Score: 0.005
  123. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26.
    View in: PubMed
    Score: 0.005
  124. Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis. HPB (Oxford). 2012 May; 14(5):325-32.
    View in: PubMed
    Score: 0.005
  125. Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation. 2012 Feb 15; 93(3):272-82.
    View in: PubMed
    Score: 0.005
  126. Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol. 2012 May; 51(5):575-83.
    View in: PubMed
    Score: 0.005
  127. The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. Transplant Proc. 1991 Dec; 23(6):3234-5.
    View in: PubMed
    Score: 0.005
  128. Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506. Transplant Proc. 1991 Dec; 23(6):3238-9.
    View in: PubMed
    Score: 0.005
  129. Hepatic blood flow plays an important role in ischemia-reperfusion injury. Liver Transpl. 2011 Dec; 17(12):1448-56.
    View in: PubMed
    Score: 0.005
  130. Patient participation in research among solid organ transplant recipients in the United States. Transplantation. 2011 Jun 27; 91(12):1424-35.
    View in: PubMed
    Score: 0.005
  131. Combined liver-kidney transplants: allosensitization and recipient outcomes. Transplantation. 2011 Jun 15; 91(11):1286-92.
    View in: PubMed
    Score: 0.005
  132. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology. 2011 Mar; 53(3):1007-19.
    View in: PubMed
    Score: 0.005
  133. Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc. 1991 Feb; 23(1 Pt 1):14-21.
    View in: PubMed
    Score: 0.005
  134. Deep hypothermia with circulatory arrest to aid in the management of suprahepatic vena cava stenosis after liver transplantation. Liver Transpl. 2010 Dec; 16(12):1434-6.
    View in: PubMed
    Score: 0.005
  135. The role of liver stromal cells in dendritic cells development in mice. Transplant Proc. 2010 Dec; 42(10):4279-81.
    View in: PubMed
    Score: 0.005
  136. The effect of thymus transplantation on allograft rejection in thymectomized bone marrow chimeras. Transplant Proc. 1990 Dec; 22(6):2536-8.
    View in: PubMed
    Score: 0.005
  137. Techniques of radiofrequency-assisted precoagulation in laparoscopic liver resection. Surg Endosc. 2011 Apr; 25(4):1143-7.
    View in: PubMed
    Score: 0.005
  138. Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis. Immunobiology. 2011 Apr; 216(4):528-34.
    View in: PubMed
    Score: 0.005
  139. A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection. Microsurgery. 2010 May; 30(4):332-7.
    View in: PubMed
    Score: 0.005
  140. Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc. 1990 Feb; 22(1):6-12.
    View in: PubMed
    Score: 0.004
  141. Liver transplantation at Cleveland Clinic. Clin Transpl. 2010; 195-206.
    View in: PubMed
    Score: 0.004
  142. Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling. Hepatology. 2009 Dec; 50(6):1981-91.
    View in: PubMed
    Score: 0.004
  143. Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients. Liver Transpl. 2009 Nov; 15(11):1557-63.
    View in: PubMed
    Score: 0.004
  144. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology. 2010 Jan; 138(1):159-64.
    View in: PubMed
    Score: 0.004
  145. Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. J Hepatol. 2009 Sep; 51(3):510-9.
    View in: PubMed
    Score: 0.004
  146. Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria. Liver Transpl. 2009 Feb; 15(2):169-76.
    View in: PubMed
    Score: 0.004
  147. Comparison of laparoscopic versus open liver tumor resection: a case-controlled study. Surg Endosc. 2009 Apr; 23(4):847-53.
    View in: PubMed
    Score: 0.004
  148. Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation. 2008 Dec 15; 86(11):1492-502.
    View in: PubMed
    Score: 0.004
  149. Transplant innovation and ethical challenges: what have we learned? A collection of perspectives and panel discussion. Cleve Clin J Med. 2008 Nov; 75 Suppl 6:S24-9; discussion S30-2.
    View in: PubMed
    Score: 0.004
  150. Triple-phase computed tomography and intraoperative flow measurements improve the management of portosystemic shunts during liver transplantation. Liver Transpl. 2008 Jan; 14(1):96-9.
    View in: PubMed
    Score: 0.004
  151. World's longest surviving liver-pancreas recipient. Liver Transpl. 2007 Jul; 13(7):957-60.
    View in: PubMed
    Score: 0.004
  152. Impact of Orthoclone OKT3 on liver transplantation. Transplant Proc. 1987 Apr; 19(2 Suppl 1):37-44.
    View in: PubMed
    Score: 0.004
  153. ICAM-1 expressed on hepatic stellate cells plays an important role in immune regulation. Microsurgery. 2007; 27(4):328-32.
    View in: PubMed
    Score: 0.004
  154. Cotransplanted hepatic stellate cells enhance vascularization of islet allografts. Microsurgery. 2007; 27(4):324-7.
    View in: PubMed
    Score: 0.004
  155. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant. 2006 Dec; 6(12):2983-93.
    View in: PubMed
    Score: 0.004
  156. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology. 2006 Nov; 44(5):1171-81.
    View in: PubMed
    Score: 0.004
  157. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol. 2006 Aug; 30(8):986-93.
    View in: PubMed
    Score: 0.003
  158. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl. 2006 May; 12(5):813-20.
    View in: PubMed
    Score: 0.003
  159. Isolated right hepatic vein obstruction after piggyback liver transplantation. Liver Transpl. 2006 May; 12(5):808-12.
    View in: PubMed
    Score: 0.003
  160. Caroli's disease and orthotopic liver transplantation. Liver Transpl. 2006 Mar; 12(3):416-21.
    View in: PubMed
    Score: 0.003
  161. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med. 2006 Jan 12; 354(2):141-50.
    View in: PubMed
    Score: 0.003
  162. Regulatory dendritic cells modulate immune responses via induction of T-cell apoptotic death. Microsurgery. 2006; 26(1):21-4.
    View in: PubMed
    Score: 0.003
  163. Immune regulatory activity of liver-derived dendritic cells generated in vivo. Microsurgery. 2006; 26(1):17-20.
    View in: PubMed
    Score: 0.003
  164. Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl. 2005 Nov; 11(11):1343-52.
    View in: PubMed
    Score: 0.003
  165. Effect of age and postoperative time on cytochrome p450 enzyme activity following liver transplantation. J Clin Pharmacol. 2005 Jun; 45(6):666-73.
    View in: PubMed
    Score: 0.003
  166. EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients. Transpl Immunol. 2005 Jun; 14(2):109-16.
    View in: PubMed
    Score: 0.003
  167. Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization. J Cancer Res Clin Oncol. 2005 Jul; 131(7):429-38.
    View in: PubMed
    Score: 0.003
  168. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg. 2005 Apr; 200(4):505-15; quiz A59-61.
    View in: PubMed
    Score: 0.003
  169. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity. Ann Surg. 2005 Mar; 241(3):497-505.
    View in: PubMed
    Score: 0.003
  170. Reversal of acute cellular rejection after renal transplantation with Campath-1H. Transplant Proc. 2005 Mar; 37(2):923-6.
    View in: PubMed
    Score: 0.003
  171. Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patients. J Clin Pharmacol. 2005 Jan; 45(1):34-41.
    View in: PubMed
    Score: 0.003
  172. Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation. 2004 Dec 15; 78(11):1683-8.
    View in: PubMed
    Score: 0.003
  173. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology. 2004 Dec; 40(6):1312-21.
    View in: PubMed
    Score: 0.003
  174. Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation. 2004 Oct 15; 78(7):966-71.
    View in: PubMed
    Score: 0.003
  175. Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation. Hepatogastroenterology. 2004 Sep-Oct; 51(59):1413-6.
    View in: PubMed
    Score: 0.003
  176. Synergistic effect of cold and warm ischemia time on postoperative graft function and outcome in human liver transplantation. Transplant Proc. 2004 Sep; 36(7):1955-8.
    View in: PubMed
    Score: 0.003
  177. De novo malignancies after intestinal and multivisceral transplantation. Transplantation. 2004 Jun 15; 77(11):1719-25.
    View in: PubMed
    Score: 0.003
  178. Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol. 2004 May; 28(5):658-69.
    View in: PubMed
    Score: 0.003
  179. Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transpl Infect Dis. 2004 Mar; 6(1):10-4.
    View in: PubMed
    Score: 0.003
  180. Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway. J Immunol. 2004 Feb 01; 172(3):1355-63.
    View in: PubMed
    Score: 0.003
  181. Minimal evidence of transdifferentiation from recipient bone marrow to parenchymal cells in regenerating and long-surviving human allografts. Am J Transplant. 2003 Sep; 3(9):1173-81.
    View in: PubMed
    Score: 0.003
  182. Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58. Transpl Int. 2003 Dec; 16(12):849-56.
    View in: PubMed
    Score: 0.003
  183. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation. 2003 Aug 27; 76(4):721-9.
    View in: PubMed
    Score: 0.003
  184. Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B. Clin Infect Dis. 2003 Jul 01; 37(1):17-25.
    View in: PubMed
    Score: 0.003
  185. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Transplantation. 2003 Apr 15; 75(7):1020-5.
    View in: PubMed
    Score: 0.003
  186. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant. 2003 Apr; 17(2):77-88.
    View in: PubMed
    Score: 0.003
  187. Longitudinal study of cryptococcosis in adult solid-organ transplant recipients. Transpl Int. 2003 May; 16(5):336-40.
    View in: PubMed
    Score: 0.003
  188. Pancreatitis after liver transplantation in children: a single-center experience. Transplantation. 2003 Jan 27; 75(2):190-3.
    View in: PubMed
    Score: 0.003
  189. Prolonged survival of heart allografts transduced with AAV-CTLA4Ig. Microsurgery. 2003; 23(5):489-93.
    View in: PubMed
    Score: 0.003
  190. Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity. Microsurgery. 2003; 23(5):494-7.
    View in: PubMed
    Score: 0.003
  191. Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol. 2002 Sep; 37(3):340-8.
    View in: PubMed
    Score: 0.003
  192. Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore). 2002 Sep; 81(5):333-48.
    View in: PubMed
    Score: 0.003
  193. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol. 2002 Aug; 104(2):138-50.
    View in: PubMed
    Score: 0.003
  194. Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center. Transplant Proc. 2002 Aug; 34(5):1955-7.
    View in: PubMed
    Score: 0.003
  195. Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury. Transplantation. 2002 Jul 15; 74(1):7-13.
    View in: PubMed
    Score: 0.003
  196. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation. 2002 May 27; 73(10):1598-602.
    View in: PubMed
    Score: 0.003
  197. Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation. 2002 Mar 27; 73(6):941-7.
    View in: PubMed
    Score: 0.003
  198. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant. 2002 Mar; 2(3):287-91.
    View in: PubMed
    Score: 0.003
  199. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology. 2002 Feb; 35(2):380-4.
    View in: PubMed
    Score: 0.003
  200. Hemorrhagic complications of enoxaparin and aspirin in patients with kidney transplants. Pharmacotherapy. 2002 Feb; 22(2):184-7.
    View in: PubMed
    Score: 0.003
  201. Influence of cold ischemia time and graft transport distance on postoperative outcome in human liver transplantation. Surg Today. 2002; 32(9):792-9.
    View in: PubMed
    Score: 0.003
  202. Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem. 2002 Mar 22; 277(12):10114-20.
    View in: PubMed
    Score: 0.003
  203. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors. Transplantation. 2001 Oct 27; 72(8):1423-32.
    View in: PubMed
    Score: 0.002
  204. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl. 2001 Oct; 7(10):863-9.
    View in: PubMed
    Score: 0.002
  205. Ethical considerations and rationale of adult-to-adult living donor liver transplantation. Liver Transpl. 2001 Oct; 7(10):921-7.
    View in: PubMed
    Score: 0.002
  206. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation. 2001 Aug 27; 72(4):619-26.
    View in: PubMed
    Score: 0.002
  207. Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease. Xenotransplantation. 2001 Aug; 8(3):213-21.
    View in: PubMed
    Score: 0.002
  208. Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells. Ther Drug Monit. 2001 Aug; 23(4):354-62.
    View in: PubMed
    Score: 0.002
  209. Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol. 2001 Jun 15; 166(12):7042-52.
    View in: PubMed
    Score: 0.002
  210. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance. J Immunol. 2001 May 01; 166(9):5619-28.
    View in: PubMed
    Score: 0.002
  211. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol. 2001 Apr; 158(4):1379-90.
    View in: PubMed
    Score: 0.002
  212. Comparison of the regulatory regions of the alpha1,3galactosyltransferase gene between murine and porcine species. Transplant Proc. 2001 Feb-Mar; 33(1-2):710-1.
    View in: PubMed
    Score: 0.002
  213. Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc. 2001 Feb-Mar; 33(1-2):1235-6.
    View in: PubMed
    Score: 0.002
  214. Occult nonhematopoietic malignancies present at autopsy in solid organ transplant patients who died within 100 days. Transplantation. 2001 Jan 15; 71(1):64-9.
    View in: PubMed
    Score: 0.002
  215. Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model. Cell Transplant. 2001; 10(3):343-50.
    View in: PubMed
    Score: 0.002
  216. Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft. Transplant Proc. 2000 Dec; 32(8):2710-2.
    View in: PubMed
    Score: 0.002
  217. Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection. Immunology. 2000 Oct; 101(2):233-41.
    View in: PubMed
    Score: 0.002
  218. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000 Oct; 191(4):389-94.
    View in: PubMed
    Score: 0.002
  219. The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc. 2000 Sep; 32(6):1197-8.
    View in: PubMed
    Score: 0.002
  220. Bacterial translocation in clinical intestinal transplantation. Transplant Proc. 2000 Sep; 32(6):1210.
    View in: PubMed
    Score: 0.002
  221. Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. Transplant Proc. 2000 Sep; 32(6):1223-4.
    View in: PubMed
    Score: 0.002
  222. Ischemia/reperfusion injury induces chronic changes in the small bowel. Transplant Proc. 2000 Sep; 32(6):1315.
    View in: PubMed
    Score: 0.002
  223. Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation. 2000 Jun 27; 69(12):2566-73.
    View in: PubMed
    Score: 0.002
  224. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. Transplantation. 2000 Jun 15; 69(11):2330-6.
    View in: PubMed
    Score: 0.002
  225. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol. 2000 May; 156(5):1627-39.
    View in: PubMed
    Score: 0.002
  226. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol Ther. 2000 May; 1(5 Pt 1):430-7.
    View in: PubMed
    Score: 0.002
  227. A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg. 2000 Apr; 119(4 Pt 1):673-81.
    View in: PubMed
    Score: 0.002
  228. Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology. 2000 Mar; 31(3):577-80.
    View in: PubMed
    Score: 0.002
  229. Influence of donor condition on postoperative graft survival and function in human liver transplantation. Transplant Proc. 2000 Mar; 32(2):322-6.
    View in: PubMed
    Score: 0.002
  230. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol. 2000 Mar; 24(3):375-85.
    View in: PubMed
    Score: 0.002
  231. Serum protein immunogenicity: implications for liver xenografting. Electrophoresis. 2000 Mar; 21(5):965-75.
    View in: PubMed
    Score: 0.002
  232. Late-onset renal failure after liver transplantation: role of posttransplant alcohol use. Transplantation. 2000 Feb 15; 69(3):383-8.
    View in: PubMed
    Score: 0.002
  233. Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci. 2000 Feb; 45(2):334-9.
    View in: PubMed
    Score: 0.002
  234. Effects of donor bone marrow infusion in clinical lung transplantation. Ann Thorac Surg. 2000 Feb; 69(2):345-50.
    View in: PubMed
    Score: 0.002
  235. Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: effect of viral hepatitis D. Liver Transpl. 2000 Jan; 6(1):92-6.
    View in: PubMed
    Score: 0.002
  236. [Experience of orthotopic liver transplantation from non-heart-beating donors at the University of Pittsburgh Medical Center]. Nihon Geka Gakkai Zasshi. 1999 Dec; 100(12):818-21.
    View in: PubMed
    Score: 0.002
  237. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. Transplantation. 1999 Nov 15; 68(9):1402-9.
    View in: PubMed
    Score: 0.002
  238. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation. 1999 Sep 27; 68(6):747-57.
    View in: PubMed
    Score: 0.002
  239. An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation. 1999 Sep 15; 68(5):650-5.
    View in: PubMed
    Score: 0.002
  240. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 1999 Sep; 189(3):291-9.
    View in: PubMed
    Score: 0.002
  241. Hyperbaric oxygen therapy for hepatic artery thrombosis after liver transplantation in children. Liver Transpl Surg. 1999 Sep; 5(5):429-36.
    View in: PubMed
    Score: 0.002
  242. Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg. 1999 Sep; 230(3):372-9; discussion 379-81.
    View in: PubMed
    Score: 0.002
  243. Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts. Transplant Proc. 1999 Aug; 31(5):2028-31.
    View in: PubMed
    Score: 0.002
  244. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology. 1999 Jul; 117(1):149-53.
    View in: PubMed
    Score: 0.002
  245. Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection. Transplantation. 1999 May 27; 67(10):1295-300.
    View in: PubMed
    Score: 0.002
  246. Role of UW solution and sodium nitroprusside in reperfusion of liver xenografts from guinea-pig to rat. Xenotransplantation. 1999 May; 6(2):117-22.
    View in: PubMed
    Score: 0.002
  247. Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil. Liver Transpl Surg. 1999 Mar; 5(2):101-6.
    View in: PubMed
    Score: 0.002
  248. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms. Transplantation. 1999 Feb 15; 67(3):444-50.
    View in: PubMed
    Score: 0.002
  249. Translocation of bacteria from the gastrointestinal tract: protection afforded by lisofylline. Transplant Proc. 1999 Feb-Mar; 31(1-2):575-6.
    View in: PubMed
    Score: 0.002
  250. Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide. Transplant Proc. 1999 Feb-Mar; 31(1-2):646-7.
    View in: PubMed
    Score: 0.002
  251. Mechanisms underlying the development of T-cell tolerance following interruption of signalling at the CD28/B7 and CD40/gp39 interface. Transplant Proc. 1999 Feb-Mar; 31(1-2):845.
    View in: PubMed
    Score: 0.002
  252. Pyruvate inhibits the chronic damage which ensues after ischemia/reperfusion injury of kidneys. Transplant Proc. 1999 Feb-Mar; 31(1-2):1033.
    View in: PubMed
    Score: 0.002
  253. Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival. Transplant Proc. 1999 Feb-Mar; 31(1-2):1242-3.
    View in: PubMed
    Score: 0.002
  254. Long-term results of pancreas transplantation under tacrolius immunosuppression. Transplantation. 1999 Jan 27; 67(2):266-72.
    View in: PubMed
    Score: 0.002
  255. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Transplantation. 1998 Dec 27; 66(12):1587-96.
    View in: PubMed
    Score: 0.002
  256. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation. 1998 Dec 27; 66(12):1596-604.
    View in: PubMed
    Score: 0.002
  257. Adenovirus-mediated gene transfer to liver grafts: an improved method to maximize infectivity. Transplantation. 1998 Dec 15; 66(11):1545-51.
    View in: PubMed
    Score: 0.002
  258. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig Dis Sci. 1998 Nov; 43(11):2459-62.
    View in: PubMed
    Score: 0.002
  259. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg. 1998 Oct; 187(4):358-64.
    View in: PubMed
    Score: 0.002
  260. Quality of life after intestinal transplantation and on total parenteral nutrition. Transplant Proc. 1998 Sep; 30(6):2513-4.
    View in: PubMed
    Score: 0.002
  261. Long-term nutritional monitoring after clinical intestinal transplantation. Transplant Proc. 1998 Sep; 30(6):2515-6.
    View in: PubMed
    Score: 0.002
  262. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation. 1998 Jun 27; 65(12):1590-8.
    View in: PubMed
    Score: 0.002
  263. Tacrolimus for rescue of refractory renal allograft rejection. Transplant Proc. 1998 Jun; 30(4):1257-60.
    View in: PubMed
    Score: 0.002
  264. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg. 1998 May; 186(5):512-25; discussion 525-7.
    View in: PubMed
    Score: 0.002
  265. Clonal and morphological variation in a posttransplant lymphoproliferative disorder: evolution from clonal T-cell to clonal B-cell predominance. Hum Pathol. 1998 Apr; 29(4):416-21.
    View in: PubMed
    Score: 0.002
  266. Liver transplantation with cavoportal hemitransposition in the presence of diffuse portal vein thrombosis. Transplantation. 1998 Mar 15; 65(5):619-24.
    View in: PubMed
    Score: 0.002
  267. Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation. Clin Pharmacol Ther. 1998 Mar; 63(3):296-302.
    View in: PubMed
    Score: 0.002
  268. Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. Transplantation. 1998 Feb 27; 65(4):499-504.
    View in: PubMed
    Score: 0.002
  269. Current status of intestinal transplantation in children. J Pediatr Surg. 1998 Feb; 33(2):243-54.
    View in: PubMed
    Score: 0.002
  270. Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. Transplantation. 1998 Jan 15; 65(1):82-6.
    View in: PubMed
    Score: 0.002
  271. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg. 1998 Jan; 4(1):22-7.
    View in: PubMed
    Score: 0.002
  272. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation. 1997 Dec 27; 64(12):1808-15.
    View in: PubMed
    Score: 0.002
  273. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation. 1997 Dec 27; 64(12):1838-43.
    View in: PubMed
    Score: 0.002
  274. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg. 1997 Nov; 185(5):429-36.
    View in: PubMed
    Score: 0.002
  275. Cardiac operations in solid-organ transplant recipients. Ann Thorac Surg. 1997 Nov; 64(5):1270-8.
    View in: PubMed
    Score: 0.002
  276. Hemodynamic effects of inhaled nitric oxide in four patients with severe liver disease and pulmonary hypertension. Liver Transpl Surg. 1997 Nov; 3(6):594-7.
    View in: PubMed
    Score: 0.002
  277. HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation. 1997 Oct 15; 64(7):983-91.
    View in: PubMed
    Score: 0.002
  278. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology. 1997 Oct; 26(4):877-83.
    View in: PubMed
    Score: 0.002
  279. Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. Transplantation. 1997 Sep 15; 64(5):690-5.
    View in: PubMed
    Score: 0.002
  280. Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation. 1997 Aug 15; 64(3):422-6.
    View in: PubMed
    Score: 0.002
  281. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology. 1997 Aug; 26(2):444-50.
    View in: PubMed
    Score: 0.002
  282. Early recipient-donor switch of the complement type after liver xenotransplantation. Immunol Invest. 1997 Aug-Dec; 26(5-7):589-600.
    View in: PubMed
    Score: 0.002
  283. Central venulitis in the allograft liver: a clinicopathologic study. Transplantation. 1997 Jul 27; 64(2):252-7.
    View in: PubMed
    Score: 0.002
  284. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology. 1997 Jul-Aug; 44(16):1172-81.
    View in: PubMed
    Score: 0.002
  285. Perioperative donor bone marrow infusion in recipients of organ allografts. Transplant Proc. 1997 Jun; 29(4):2192-3.
    View in: PubMed
    Score: 0.002
  286. An attempt to reverse diabetes by delayed islet cell transplantation in humans. Transplant Proc. 1997 Jun; 29(4):2238-9.
    View in: PubMed
    Score: 0.002
  287. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol. 1997 May 15; 158(10):4654-61.
    View in: PubMed
    Score: 0.002
  288. Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. Transplantation. 1997 May 15; 63(9):1200-5.
    View in: PubMed
    Score: 0.002
  289. Survival and quality of life after liver transplantation for acute alcoholic hepatitis. Liver Transpl Surg. 1997 May; 3(3):240-4.
    View in: PubMed
    Score: 0.002
  290. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol. 1997 Feb; 150(2):563-78.
    View in: PubMed
    Score: 0.002
  291. Five-year experience with tacrolimus rescue for renal allograft rejection. Transplant Proc. 1997 Feb-Mar; 29(1-2):306.
    View in: PubMed
    Score: 0.002
  292. Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. Transplant Proc. 1997 Feb-Mar; 29(1-2):310.
    View in: PubMed
    Score: 0.002
  293. Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. Transplant Proc. 1997 Feb-Mar; 29(1-2):454-5.
    View in: PubMed
    Score: 0.002
  294. High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1081-2.
    View in: PubMed
    Score: 0.002
  295. Gastrointestinal bleeding after liver transplantation. Transplantation. 1997 Jan 15; 63(1):60-7.
    View in: PubMed
    Score: 0.002
  296. An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients. Adv Exp Med Biol. 1997; 417:269-74.
    View in: PubMed
    Score: 0.002
  297. Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. Transplantation. 1996 Dec 27; 62(12):1709-14.
    View in: PubMed
    Score: 0.002
  298. "Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. Transplantation. 1996 Nov 15; 62(9):1242-6.
    View in: PubMed
    Score: 0.002
  299. Cytokine profile in graft-versus-host disease after small bowel transplantation. Transplant Proc. 1996 Oct; 28(5):2455.
    View in: PubMed
    Score: 0.002
  300. Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc. 1996 Oct; 28(5):2959-65.
    View in: PubMed
    Score: 0.002
  301. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation. 1996 Sep 15; 62(5):659-65.
    View in: PubMed
    Score: 0.002
  302. Tacrolimus rescue therapy for renal transplant rejection. Transplant Proc. 1996 Aug; 28(4):2119-20.
    View in: PubMed
    Score: 0.002
  303. Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. Transplantation. 1996 Jun 27; 61(12):1730-5.
    View in: PubMed
    Score: 0.002
  304. Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts. Transplant Proc. 1996 Jun; 28(3):1229-34.
    View in: PubMed
    Score: 0.002
  305. Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report. Transplant Proc. 1996 Jun; 28(3):1237-40.
    View in: PubMed
    Score: 0.002
  306. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res. 1996 Feb 01; 60(2):333-8.
    View in: PubMed
    Score: 0.002
  307. Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity. J Clin Invest. 1996 Jan 01; 97(1):217-25.
    View in: PubMed
    Score: 0.002
  308. Effect of donor age and sex on the outcome of liver transplantation. Hepatology. 1995 Dec; 22(6):1754-62.
    View in: PubMed
    Score: 0.002
  309. Fine-needle aspiration biopsy in pancreatic transplantation. Transplant Proc. 1995 Dec; 27(6):3055-6.
    View in: PubMed
    Score: 0.002
  310. Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol. 1995 Nov; 2(6):483-7.
    View in: PubMed
    Score: 0.002
  311. Patterns of inflammatory vascular endothelial changes in murine liver grafts. Transplantation. 1995 Sep 27; 60(6):577-84.
    View in: PubMed
    Score: 0.002
  312. Varicella-zoster virus hepatitis and a suggested management plan for prevention of VZV infection in adult liver transplant recipients. Transplantation. 1995 Sep 27; 60(6):619-21.
    View in: PubMed
    Score: 0.002
  313. Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. Transplantation. 1995 Sep 15; 60(5):512-4.
    View in: PubMed
    Score: 0.002
  314. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med. 1995 Aug 01; 182(2):379-87.
    View in: PubMed
    Score: 0.002
  315. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation. 1995 Jul 27; 60(2):158-71.
    View in: PubMed
    Score: 0.002
  316. Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance. Hepatology. 1995 May; 21(5):1345-52.
    View in: PubMed
    Score: 0.002
  317. Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. Transplant Proc. 1995 Apr; 27(2):1862-7.
    View in: PubMed
    Score: 0.002
  318. In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation. Transplantation. 1995 Feb 27; 59(4):544-51.
    View in: PubMed
    Score: 0.002
  319. One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. Transplant Proc. 1995 Feb; 27(1):1099-104.
    View in: PubMed
    Score: 0.002
  320. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol. 1995 Feb; 19(2):192-206.
    View in: PubMed
    Score: 0.002
  321. Propagation of cells expressing donor phenotype (MHC class I, II and Y-chromosome) from the bone marrow of murine liver allograft recipients in response to GM-CSF in vitro. Transplant Proc. 1995 Feb; 27(1):191-3.
    View in: PubMed
    Score: 0.002
  322. Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study. Transplant Proc. 1995 Feb; 27(1):207-9.
    View in: PubMed
    Score: 0.002
  323. Suppression of alloreactive T-cell activation by murine liver F4/80+ accessory cells and kinetics of intrahepatic F4/80+ cells following liver transplantation. Transplant Proc. 1995 Feb; 27(1):520-1.
    View in: PubMed
    Score: 0.002
  324. Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience. Transplant Proc. 1995 Feb; 27(1):710-2.
    View in: PubMed
    Score: 0.002
  325. Acute pancreatitis after liver transplantation: incidence and contributing factors. Transpl Int. 1995; 8(1):1-7.
    View in: PubMed
    Score: 0.002
  326. Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg. 1995 Jan; 180(1):1-9.
    View in: PubMed
    Score: 0.002
  327. Three years clinical experience with intestinal transplantation. J Am Coll Surg. 1994 Oct; 179(4):385-400.
    View in: PubMed
    Score: 0.002
  328. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation. 1994 Jul 15; 58(1):1-8.
    View in: PubMed
    Score: 0.002
  329. Interferon-gamma induced expression of MHC antigens facilitates identification of donor cells in chimeric transplant recipients. Cell Transplant. 1994 Jul-Aug; 3(4):345-8.
    View in: PubMed
    Score: 0.002
  330. Disease gravity and urgency of need as guidelines for liver allocation. Hepatology. 1994 Jul; 20(1 Pt 2):56S-62S.
    View in: PubMed
    Score: 0.002
  331. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology. 1994 Apr; 19(4):916-24.
    View in: PubMed
    Score: 0.001
  332. Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection. Transplantation. 1994 Mar 27; 57(6):918-22.
    View in: PubMed
    Score: 0.001
  333. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc. 1993 Dec; 25(6):3337-44.
    View in: PubMed
    Score: 0.001
  334. Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). Ann Intern Med. 1993 Oct 01; 119(7 Pt 1):595-8.
    View in: PubMed
    Score: 0.001
  335. Combined veno-venous bypass and high volume hemofiltration during orthotopic liver transplantation. ASAIO J. 1993 Oct-Dec; 39(4):954-6.
    View in: PubMed
    Score: 0.001
  336. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet. 1993 Oct; 177(4):335-44.
    View in: PubMed
    Score: 0.001
  337. Evidence for early Th 2 T cell predominance in xenoreactivity. Transplantation. 1993 Oct; 56(4):905-11.
    View in: PubMed
    Score: 0.001
  338. Dendritic cell replacement in long-surviving liver and cardiac xenografts. Transplantation. 1993 Aug; 56(2):482-4.
    View in: PubMed
    Score: 0.001
  339. Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc. 1993 Aug; 25(4):2433-4.
    View in: PubMed
    Score: 0.001
  340. Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc. 1993 Aug; 25(4):2435.
    View in: PubMed
    Score: 0.001
  341. Hamster coagulation and serum proteins in rat recipients of hamster xenografts. Transplantation. 1993 Aug; 56(2):489-90.
    View in: PubMed
    Score: 0.001
  342. Posttransplant hypertension in blacks versus nonblacks. Transplant Proc. 1993 Aug; 25(4):2456-7.
    View in: PubMed
    Score: 0.001
  343. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. Am J Pathol. 1993 Jul; 143(1):85-98.
    View in: PubMed
    Score: 0.001
  344. Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats. Cell Transplant. 1993 Jul-Aug; 2(4):345-53.
    View in: PubMed
    Score: 0.001
  345. Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. Transplant Proc. 1993 Jun; 25(3):2381-5.
    View in: PubMed
    Score: 0.001
  346. Clinical intestinal transplantation. Transplant Proc. 1993 Jun; 25(3):2195-7.
    View in: PubMed
    Score: 0.001
  347. Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. Am J Pathol. 1993 May; 142(5):1383-91.
    View in: PubMed
    Score: 0.001
  348. Intestinal transplantation in humans under FK 506. Transplant Proc. 1993 Feb; 25(1 Pt 2):1198-9.
    View in: PubMed
    Score: 0.001
  349. Nutritional management of intestinal transplant recipients. Transplant Proc. 1993 Feb; 25(1 Pt 2):1200-1.
    View in: PubMed
    Score: 0.001
  350. Xenoreactivity in mouse + rat-->mouse chimeras. Transplant Proc. 1993 Feb; 25(1 Pt 1):455-6.
    View in: PubMed
    Score: 0.001
  351. Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine. Transplant Proc. 1993 Feb; 25(1 Pt 1):704-5.
    View in: PubMed
    Score: 0.001
  352. Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation. Transplant Proc. 1993 Feb; 25(1 Pt 2):888-90.
    View in: PubMed
    Score: 0.001
  353. Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases. Transplant Proc. 1992 Dec; 24(6):3038-9.
    View in: PubMed
    Score: 0.001
  354. Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin. Transplant Proc. 1992 Aug; 24(4):1403-5.
    View in: PubMed
    Score: 0.001
  355. Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol. 1992 Jun; 128(6):781-5.
    View in: PubMed
    Score: 0.001
  356. Management of intestinal transplantation in humans. Transplant Proc. 1992 Jun; 24(3):1243-4.
    View in: PubMed
    Score: 0.001
  357. Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage. Transplant Proc. 1992 Jun; 24(3):1143-4.
    View in: PubMed
    Score: 0.001
  358. Clinical intestinal transplantation: focus on complications. Transplant Proc. 1992 Jun; 24(3):1238-40.
    View in: PubMed
    Score: 0.001
  359. Survival of human hepatocellular aggregates in athymic mice. Transplant Proc. 1992 Jun; 24(3):986.
    View in: PubMed
    Score: 0.001
  360. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation. 1992 May; 53(5):1056-62.
    View in: PubMed
    Score: 0.001
  361. Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants. Am J Pathol. 1992 May; 140(5):1255-60.
    View in: PubMed
    Score: 0.001
  362. Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation. 1992 Feb; 53(2):407-14.
    View in: PubMed
    Score: 0.001
  363. Interaction between FK 506 and cyclosporine in dogs. Transplant Proc. 1991 Dec; 23(6):2797-9.
    View in: PubMed
    Score: 0.001
  364. The pharmacodynamics of pentobarbital following FK 506 therapy. Transplant Proc. 1991 Dec; 23(6):2800-1.
    View in: PubMed
    Score: 0.001
  365. Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report. Transplant Proc. 1991 Dec; 23(6):3016-8.
    View in: PubMed
    Score: 0.001
  366. The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis. Transplant Proc. 1991 Dec; 23(6):3021-2.
    View in: PubMed
    Score: 0.001
  367. Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant. Transplant Proc. 1991 Dec; 23(6):3023-5.
    View in: PubMed
    Score: 0.001
  368. CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression. Transplant Proc. 1991 Dec; 23(6):3035-7.
    View in: PubMed
    Score: 0.001
  369. Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. Transplant Proc. 1991 Dec; 23(6):3044-6.
    View in: PubMed
    Score: 0.001
  370. Clinical small bowel or small bowel plus liver transplantation under FK 506. Transplant Proc. 1991 Dec; 23(6):3093-5.
    View in: PubMed
    Score: 0.001
  371. FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. Transplant Proc. 1991 Dec; 23(6):3225-7.
    View in: PubMed
    Score: 0.001
  372. Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. Transplant Proc. 1991 Dec; 23(6):3269-71.
    View in: PubMed
    Score: 0.001
  373. FK 506: a new therapeutic agent for severe recalcitrant psoriasis. Transplant Proc. 1991 Dec; 23(6):3322-4.
    View in: PubMed
    Score: 0.001
  374. Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases. Transplant Proc. 1991 Dec; 23(6):3325-7.
    View in: PubMed
    Score: 0.001
  375. Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc. 1991 Dec; 23(6):3328-9.
    View in: PubMed
    Score: 0.001
  376. [Clinical experience with FK 506]. Presse Med. 1991 Nov 27; 20(40):1967-73.
    View in: PubMed
    Score: 0.001
  377. Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. Transplantation. 1991 Oct; 52(4):590-4.
    View in: PubMed
    Score: 0.001
  378. Orthotopic liver transplantation in the mouse. Transplantation. 1991 Sep; 52(3):562-4.
    View in: PubMed
    Score: 0.001
  379. FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. Surgery. 1991 Aug; 110(2):357-63; discussion 363-4.
    View in: PubMed
    Score: 0.001
  380. The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation. 1991 Jul; 52(1):71-7.
    View in: PubMed
    Score: 0.001
  381. Liver transplantation under cyclosporine: a decade of experience. Transplant Proc. 1991 Feb; 23(1 Pt 2):1393-6.
    View in: PubMed
    Score: 0.001
  382. Allogeneic orthotopic liver transplantation in mice: a preliminary study of rejection across well-defined MHC barriers. Transplant Proc. 1991 Feb; 23(1 Pt 1):705-6.
    View in: PubMed
    Score: 0.001
  383. The liver transplant waiting list--a single-center analysis. Transplantation. 1991 Jan; 51(1):128-34.
    View in: PubMed
    Score: 0.001
  384. Liver transplantation in patients over sixty years of age. Transplantation. 1991 Jan; 51(1):271-3.
    View in: PubMed
    Score: 0.001
  385. Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery. 1990 Nov; 108(5):880-9.
    View in: PubMed
    Score: 0.001
  386. Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg. 1990 Sep; 212(3):295-305; discussion 306-7.
    View in: PubMed
    Score: 0.001
  387. Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet. 1990 Aug 18; 336(8712):402-5.
    View in: PubMed
    Score: 0.001
  388. FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood. Lancet. 1990 Mar 17; 335(8690):674.
    View in: PubMed
    Score: 0.001
  389. The University of Pittsburgh: a three and three-quarter-year experience with cadaveric renal transplantation under the point system. Clin Transpl. 1989; 287-93.
    View in: PubMed
    Score: 0.001
  390. Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg. 1988 Aug; 208(2):196-202.
    View in: PubMed
    Score: 0.001
  391. Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants. Nephron. 1987; 46 Suppl 1:56-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.